Re: Bob & bospenc Re: MannKind Corp. (MNKD) to Release Earnings on Friday
|
2
|
Mannkind
|
Aug 08, 2013 05:32PM
|
MannKind Corp. Coverage Initiated by Analysts at Brinson Patrick (MNKD)
|
2
|
Mannkind
|
Jun 24, 2013 01:47PM
|
Just a reminder
|
2
|
Mannkind
|
Jun 18, 2012 11:12PM
|
Re: Fast Track
|
2
|
Mannkind
|
Aug 15, 2013 10:25AM
|
Re: Why has this stock being doing well lately?
|
2
|
Mannkind
|
Aug 30, 2012 04:29PM
|
Just in case anyone's interested
|
2
|
Mannkind
|
Sep 11, 2012 06:18PM
|
This proves that I have too much time on my hands...
|
2
|
Mannkind
|
Jan 09, 2013 04:06PM
|
MannKind Nears End of Clinical Trial, Medical Breakthrough
|
2
|
Mannkind
|
Jul 23, 2013 04:08PM
|
Follow the Herd of Bulls Into Small Cap MannKind Corporation (MNKD)?
|
2
|
Mannkind
|
Aug 21, 2012 12:25PM
|
Re: My experience is similar to the other poster who was in an earlier trial
|
2
|
Mannkind
|
Apr 01, 2013 09:22PM
|
Re: Mann Research Center to begin construction by year's end in Tradition Center for
|
2
|
Mannkind
|
Oct 31, 2012 11:10AM
|
Re: Exubera: The Rise and Fall of Inhalable Insulin
|
2
|
Mannkind
|
May 29, 2012 01:41PM
|
Zacks
|
2
|
Mannkind
|
Nov 15, 2012 01:33PM
|
Australian Design Certification Round-Up 21 June 2012
|
2
|
Mannkind
|
Jun 21, 2012 10:15AM
|
Bristol Myers Squibb (BMY) Nabs Diabetes Player Amylin Pharmaceuticals (AMLN). W
|
2
|
Mannkind
|
Jul 02, 2012 02:48PM
|
Re: Thanks
|
2
|
Mannkind
|
Aug 28, 2012 02:47PM
|
There's a lot of excitement .....
|
2
|
Mannkind
|
Jun 05, 2013 10:13AM
|
Re: Silentbobsilent sorts out the Exubera Study
|
2
|
Mannkind
|
Sep 06, 2012 03:11PM
|
MannKind Upgraded by JMP Securities to “Market outperform” (MNKD)
|
2
|
Mannkind
|
Aug 10, 2012 10:15AM
|
Re: The Ideal Diabetes Therapy: What Will It Look Like?How Close Are We?
|
2
|
Mannkind
|
Oct 29, 2012 05:31PM
|